PROJECT 3 CONSEQUENCE OF NOVEL COCAINE PHARMACOTHERAPIES ON NEUROCHEMISTRY IN RODENT MODELS OF COCAINE DEPENDENCE Allyn Howlett, Director; Rong Chen and Steven Childers, Co-Investigators SUMMARY Cocaine addiction produces neuroadaptations in multiple neurotransmitter systems that perpetuate cocaine relapse. We hypothesize that neurochemical neuroadaptions resulting from cocaine self-administration will be modified by drug combinations that consists of an agonist pharmacotherapy with a cognitive remediator. Project 3 will delineate how these neuroadaptions can be treated with a cocaine-substitute (agonist) drug, phendimetrazine (active form is phenmetrazine (PM)), combined with Drug B candidates that serve as cognitive remediators, as identified by cognition testing in Project 1. We will examine the cellular and molecular mechanisms by which these combination medications modify brain neurochemistry to reduce cocaine self- administration and reverse cognitive deficits produced by cocaine.
Aim 1 will determine the impact of PM in combination with Drug B cognitive remediators on neuroadaptations associated with chronic cocaine self- administration in rats, beginning with the mGluR2/3 agonist LY-379268. We will examine the ventral tegmental area (VTA), nucleus accumbens (NAc), prefrontal cortex (PFC) and other limbic areas for changes in: 1) gene expression determined by quantitative PCR; 2) membrane expression of receptors and transporters assessed by radioligand binding; 3) receptor function by GTP?S binding; 4) trafficking of receptors and transporters assayed by tissue fractionation and Western blotting; 5) signal transduction determined by phosphorylation of regulatory proteins.
Aim 2 will determine the differential role of D2 autoreceptors and postsynaptic D2 receptors in NAc (using Intracranial lentivirus delivering siRNA constructs) in the mechanism of action of drug combination pharmacotherapies determined by Project 1. Experiments will determine: neuroadaptations of intra-VTA or intra-NAc knockdown of D2 receptors; how neuroadaptations of PM alone or in combination with drug B are modified by D2 autoreceptor or postsynaptic D2 receptor knockdown; how neuroadaptations of cocaine self-administration are modified by D2 autoreceptor or postsynaptic D2 receptor knockdown; and the efficacy of drug combinations on normalization of neuroadaptations in D2 knockdown animals self- administering cocaine. These neurochemical data will explain mechanisms for the development of addiction and cognitive deficits associated with cocaine self-administration, and will define how PM and cognition remediators function at the neuronal level. Since the animals used in Project 3 will be essentially the same as those used in Project 2, biochemical data from Project 3 can be directly compared with voltammetry, microdialysis, and neuronal activity data from Project 2. These results will provide pharmacodynamic evidence needed for rational design of clinical studies of novel drug combinations in addiction treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA006634-25
Application #
9232106
Study Section
Special Emphasis Panel (ZDA1-NXR-B)
Project Start
Project End
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
25
Fiscal Year
2017
Total Cost
$334,620
Indirect Cost
$118,736
Name
Wake Forest University Health Sciences
Department
Type
Domestic Higher Education
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Brodnik, Zachary D; Ferris, Mark John; Jones, Sara R et al. (2016) Reinforcing Doses of Intravenous Cocaine Produce Only Modest Dopamine Uptake Inhibition. ACS Chem Neurosci :
Eldeeb, Khalil; Leone-Kabler, Sandra; Howlett, Allyn C (2016) CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. J Basic Clin Physiol Pharmacol 27:311-22
Porrino, Linda J; Beveridge, Thomas J R; Smith, Hilary R et al. (2016) Functional consequences of cocaine expectation: findings in a non-human primate model of cocaine self-administration. Addict Biol 21:519-29
Karkhanis, Anushree N; Beveridge, Thomas J R; Blough, Bruce E et al. (2016) The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine. Drug Alcohol Depend 166:51-60
McGinnis, Molly M; Siciliano, Cody A; Jones, Sara R (2016) Dopamine D3 autoreceptor inhibition enhances cocaine potency at the dopamine transporter. J Neurochem 138:821-9
Czoty, P W; Blough, B E; Fennell, T R et al. (2016) Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys. Neuroscience 324:367-76
Porrino, Linda J; Miller, Mack D; Smith, Hilary R et al. (2016) Neural Correlates of Exposure to Cocaine Cues in Rhesus Monkeys: Modulation by the Dopamine Transporter. Biol Psychiatry :
Siciliano, Cody A; Fordahl, Steve C; Jones, Sara R (2016) Cocaine Self-Administration Produces Long-Lasting Alterations in Dopamine Transporter Responses to Cocaine. J Neurosci 36:7807-16
Gould, R W; Czoty, P W; Porrino, L J et al. (2016) Social Status in Monkeys: Effects of Social Confrontation on Brain Function and Cocaine Self-Administration. Neuropsychopharmacology :
Brust, Tarsis F; Morgenweck, Jenny; Kim, Susy A et al. (2016) Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Sci Signal 9:ra117

Showing the most recent 10 out of 291 publications